套住了 止损查看全文
牛唐2020-06-19 14:01
生物医药领域成为疫情期间IPO的亮点,在过去两个月里,包括$Lyra Therapeutics(LYRA)$ 在内,有4家上市公司都属于生物医药的范畴,包括$ORIC制药(ORIC)$ ,$Keros(KROS)$ ,以及Zentalis Pharmaceuticals。这些生物医药公司不仅顺利IPO,而且平均回报率达82%查看全文
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-023335 Size: 5 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-023336 Size: 6 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-023337 Size: 5 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-023339 Size: 5 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-023342 Size: 5 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-023341 Size: 5 KB 网页链接
$Lyra Therapeutics(LYRA)$ 8-K Current report, item 5.07 Accession Number: 0001564590-22-023497 Act: 34 Size: 174 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-022154 Size: 4 KB 网页链接
$Lyra Therapeutics(LYRA)$ 8-K Current report, items 1.01 and 2.03 Accession Number: 0001193125-22-163916 Act: 34 Size: 145 KB 网页链接
$Lyra Therapeutics(LYRA)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-22-001554 Act: 33 Size: 1 KB 网页链接